| Title | Organization | Keywords | LOI Due Date | Application Due Date |
|---|---|---|---|---|
| Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional) | National Institutes of Health | Environmental Risks, Community Engagement, | 6/5/2025 | |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required) | National Institutes of Health | investigator-initiated trial, prevention, dectetion, organ system, translational, genetic, biochemical, | 4/25/2025 | 5/25/2025 |
| Mission Boost Grants (MBG) | American Cancer Society (ACS) | OAFS, Patient-centered cancer research, community engagement | 6/1/2025 | |
| Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional) | National Institutes of Health | Physician-Scientist, Environmental Contaminants, Immuno-oncology, Cancer Prevention, Limited | 4/28/2025 | 5/28/2025 |
| (NOSI): RNA Modifications in Cancer Biology | National Cancer Institute | Precision prevention, AI, high risk, prevention strategies | 1/7/2026 | |
| (NOSI): Research on HIV - associated Malignancies | National Cancer Institute | Social, behavioral , communication, education, strategies, prevention, early detection, treatment | 9/7/2026 | |
| (NOSI): Research Projects to Develop Oncoaging Models for Cancer Research | National Cancer Institute | Equity, equitable care, interventions | 7/30/2027 | |
| (NOSI): National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Prevention | National Cancer Institute | Mentored Research, Development Awards, Down syndrome | 5/7/2029 | |
| (NOSI): Epidemiology and Prevention in Alcohol Research | National Institutes of Health | alcohol, epidemiology, prevention, research | 9/5/2026 | |
| PCF Challenge Awards | Prostate Cancer Foundation | OAFS, Prostate cancer research, Prostate Cancer Foundation, young investigators, health disparities | 5/5/2025 | |
| Collaborative Research Development Grant | Ovarian Cancer Research Alliance | OAFS, Interdisciplinary collaborations, screening and early detection, etiology and prevention, molecular therapeutics, cancer biology and genetics | 3/26/2025 | 6/15/2025 |
| Collaborative Research Development Grant – Microsoft AI for Health | Ovarian Cancer Research Alliance | OAFS, Interdisciplinary collaborations, screening and early detection, etiology and prevention, molecular therapeutics, cancer biology and genetics, AI, Artificial Intelligence | 3/26/2025 | 6/15/2025 |
| (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk | National Cancer Institute | disparities, epidemiology, | 5/9/2026 | |
| (NOSI): Chemical Countermeasures Research Program (CCRP) Administrative Supplements to Promote the Development of Pediatric Research Models of Chemical Injury and Medical Countermeasures Discovery | National Institutes of Health | supplement, pediatric, health disparities, injury, chemistry | 3/17/2026 | |
| (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First - Time Recipients of NIH Research Project Grant Awards | National Institutes of Health | NOSI, health disparities, biomedical, behavioral, communication | 10/1/2025 | |
| The NCI Worta McCaskill - Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional) | National Cancer Institute | Community oncology, Cancer prevention research, Career development, Clinical trials, early career | 6/18/2025 | |
| (NOSI): Advancing Diet and Physical Activity Biomarkers for Assessing Lifestyle Interventions in Cancer Prevention and Cancer Interception Research | National Cancer Institute | Prevention, diet, interception | 1/8/2027 | |
| HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required) | National Institutes of Health | pain management, analgesics, substance use, career development, clinical trials | 6/12/2025 | |
| (NOSI): Improving Adherence to Treatment and Prevention Regimens and Maintenance of Health Behaviors to Promote Health | National Institutes of Health | Treatment, prevention, health behaviors | 7/14/2027 | |
| (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments | National Cancer Institute | Community, prevention, implementation | 1/8/2028 | |
| (NOSI): Advancing Diet and Physical Activity Biomarkers for Assessing Lifestyle Interventions in Cancer Prevention and Cancer Interception Research | National Cancer Institute | biomarkers, lifestyle interventions, prevention, interception, diet, physical activity | 1/8/2027 | |
| (NOSI): Analysis of Existing Linked Datasets to Understand the Relationship between Housing Program Participation and Risk for Chronic Diseases and Other Conditions (R01-Clinical Trial Not Allowed) | National Institutes of Health | health disparities | 9/8/2027 | |
| Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Statistical Center (DMASC) (UG1 Clinical Trial Required) | National Cancer Institute | prevention, clinical trials, network, data management, biostatistics | 10/1/2024 | 10/31/2024 |
| ASTRO-BCRF Emerging Investigator Award to Build a Diverse Scientific Workforce | American Society for Radiation Oncology | OAFS, Training, career development, health disparities | 1/31/2025 | |
| INSPIRE Research Challenge | World Cancer Research Fund International | OAFS, International, diet, nutrition, physical activity, prevention, early detection, survivorship, global health | 10/1/2024 | 2/5/2025 |
| Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) | National Cancer Institute | preventative, clinical trials, planning, pilot studies | 5/26/2025 | 6/25/2025 |
| Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) | National Cancer Institute | preventative, clinical trials, planning, feasibility studies | 5/26/2025 | 6/25/2025 |
| Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) | National Cancer Institute | alcohol, risk reduction, prevention, public health, behavioral interventions, epidemiology | 6/5/2025 | |
| (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments | National Cancer Institute | prevention, control | 1/8/2028 | |
| Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required) | National Institutes of Health | SBIRT/P, Health Disparities, Clinical Trial, Adult Populations | 6/5/2025 | |
| Investigator-Initiated Research Grant Program | American Institute for Cancer Research (AICR) | OAFS, prevention, treatment, survival, diet, nutrition, body composition, physical activity, sleep, stress, early career, outcomes | 1/17/2025 | 5/16/2025 |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) | National Cancer Institute | Health Equity Research, Specifically named cancers (Various Cancer Types), Community Exposures | 6/18/0275 | |
| National Cancer Institute | Health disparities | 6/5/2025 | ||
| National Cancer Institute | Health disparities | 6/18/0275 | ||
| Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) | National Institutes of Health | cancer prevention, clinical trials, intervention, lifestyle factors, environmental exposures | 5/6/2025 | 6/5/2025 |
| Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed) | National Cancer Institute | natural products, interception, chemoprevention | 5/14/2025 | 6/13/2025 |
| Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional) | National Institutes of Health | stigma reduction, prevention, treatment, care, HIV, AIDS | 11/20/2024 | 12/22/2025 |
| Genomic Community Resources (U24 Clinical Trial Not Allowed) | National Institutes of Health | genomics resources, data sharing, collaboration | 7/27/2025 | 9/25/2025 |
| HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required) | National Institutes of Health | substance use, prevention, treatment, implementation | 6/12/2025 | |
| Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) | National Cancer Institute | Health Equity Research, Specifically named cancers (Various Cancer Types), Community Exposures | 6/16/2025 | |
| (NOSI): Mechanisms Driving Obesity and Prostate Cancer Risk | National Cancer Institute | prostate, risk, prevention | 1/8/2028 | |
| Academic - Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) | National Cancer Institute | Health Equity Research, Specifically named cancers (Various Cancer Types), Community Exposures | 6/5/2025 | |
| Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed) | National Institutes of Health | health disparities, Latin America, chronic | 5/6/2025 | 6/5/2025 |
| 2025 LCRF Research Grant on Prevention and Early Detection in Lung Cancer | Lung Cancer Research Foundation | OAFS, prevention, early detection, initiatives, lung | 3/3/2025 | 6/2/2025 |
| 2025 LCRF Minority Career Development Award (CDA) in Lung Cancer | Lung Cancer Research Foundation | OAFS, minority, career development, diversity, health disparities | 3/3/2025 | 6/2/2025 |
| Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) | National Institutes of Health | Cancer Health Disparities, Cutting-Edge Technologies, Digital Pathomics, Investigator-Initiated Research | 6/5/2025 | |
| NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional) | National Institutes of Health | Early Career Investigator, Cancer Disparities, Gene Editing, Cancer Health Disparities | 6/5/2025 | |
| (NOSI): Addressing Cancer-Related Financial Hardship to Improve Patient Outcomes | National Institutes of Health | health equity, socioeconomic factors, healthcare access | 1/8/2028 | |
| Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required) | National Institutes of Health | health disparities, Latin America, chronic diseases, intervention | 5/6/2025 | 6/5/2025 |
| Leadership and Coordination Center (LACC) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trials Not Allowed) | National Institutes of Health | cohort study, U01, health disparities, epidemiology, public health, HIV, cardiovascular | 4/2/2025 | 5/2/2025 |
| Health Equity and Inclusiveness Research Fellow Award | LUNGevity | OAFS, lung, fellowship, underrepresented populations, healthcare disparities, mentorship, public health, career development, training | 2/14/2025 | 5/12/2025 |
| New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed) | National Institutes of Health | Early Career, career development, Small Grant, Health Disparities, Mentorship, Innovation | 5/26/2025 | 6/26/2025 |
| Cancer Health Equity Research Centers | American Cancer Society (ACS) | OAFS, disparities, underserved populations, minorities, access, prevention, treatment, outcomes, community, public health, population science | 3/17/2025 | 6/1/2025 |
| Career Development Award (Winn CDA) | Bristol-Myers Squibb Foundation | OAFS, clinical trials, mentorship, workforce development, community, health outcomes, clinical investigator, early-stage, Training | 5/12/2025 | |
| Damon Runyon-Dale F. Frey Award for Breakthrough Scientists Overview | Damon Runyon Cancer Research Foundation | OAFS, postdoctoral, fellows, mentorship, prevention, treatment, innovation | 7/15/2025 |
